JETEMA Co Ltd Ordinary Shares 216080
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 16,580.00–16,820.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 16,670.00 / KRW 16,680.00
- Market Cap
- KRW 297.88 Bil
- Volume/Avg
- 18,536 / 36,293
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.10
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
JETEMA Co Ltd is a bio venture company. It offers products such as Botulinum toxin, Filler, Anti-aging solutions. The company also offers medical devices and cosmetics.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 213
- Website
- http://www.jetema.com
Comparables
Valuation
|
Metric
|
216080
|
085660
|
145720
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 10.69 |
Price/Book Value | 4.28 | 3.52 | 2.17 |
Price/Sales | 5.10 | 1.08 | 2.56 |
Price/Cash Flow | 31.41 | 39.64 | 8.82 |
Price/Earnings
216080
085660
145720
Financial Strength
|
Metric
|
216080
|
085660
|
145720
|
|---|---|---|---|
Quick Ratio | — | 0.67 | 0.86 |
Current Ratio | 0.61 | 0.78 | 1.45 |
Interest Coverage | 1.04 | −0.01 | 18.99 |
Quick Ratio
216080
085660
145720
Profitability
|
Metric
|
216080
|
085660
|
145720
|
|---|---|---|---|
Return on Assets (Normalized) | 1.89% | −0.51% | 13.59% |
Return on Equity (Normalized) | 7.25% | −2.90% | 23.58% |
Return on Invested Capital (Normalized) | 7.76% | 0.33% | 16.32% |
Return on Assets
216080
085660
145720
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Btcvxzggk | Gmdh | $586.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Fwvjyjjy | Fqkthts | $115.1 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Lmdcvzt | Kjsfb | $108.2 Bil | |
MRNA
| Moderna Inc | Vkrmsjhk | Zss | $54.0 Bil | |
ARGX
| argenx SE ADR | Zbmsbjc | Ycmy | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Pmbfsnsd | Dcz | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Grzvmgbw | Cxdszb | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Mqtgdwm | Rxnhg | $14.6 Bil | |
INCY
| Incyte Corp | Ttxtgqx | Jzmbcq | $12.9 Bil | |
RPRX
| Royalty Pharma PLC Class A | Pkxjklnm | Hrgsdq | $12.3 Bil |